Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

268 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multiple sclerosis tremor and the Stewart-Holmes manoeuvre.
Waubant E, Tezenas du Montcel S, Jedynak C, Obadia M, Hosseini H, Damier P, Lubetzki C, Agid Y, Degos JD. Waubant E, et al. Among authors: lubetzki c. Mov Disord. 2003 Aug;18(8):948-52. doi: 10.1002/mds.10454. Mov Disord. 2003. PMID: 12889088
[Monoclonal antibodies in multiple sclerosis].
Papeix C, Lubetzki C. Papeix C, et al. Among authors: lubetzki c. Med Sci (Paris). 2009 Dec;25(12):1113-5. doi: 10.1051/medsci/200925121113. Med Sci (Paris). 2009. PMID: 20035688 Free article. Review. French.
[Current treatment for multiple sclerosis].
Papeix C, Lubetzki C, Lyon-Caen O. Papeix C, et al. Among authors: lubetzki c. Presse Med. 2010 Mar;39(3):381-8. doi: 10.1016/j.lpm.2009.05.021. Epub 2010 Jan 27. Presse Med. 2010. PMID: 20106633 French.
MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis.
International Multiple Sclerosis Genetics Consortium; Lill CM, Schjeide BM, Graetz C, Ban M, Alcina A, Ortiz MA, Pérez J, Damotte V, Booth D, Lopez de Lapuente A, Broer L, Schilling M, Akkad DA, Aktas O, Alloza I, Antigüedad A, Arroyo R, Blaschke P, Buttmann M, Chan A, Compston A, Cournu-Rebeix I, Dörner T, Epplen JT, Fernández Ó, Gerdes LA, Guillot-Noël L, Hartung HP, Hoffjan S, Izquierdo G, Kemppinen A, Kroner A, Kubisch C, Kümpfel T, Li SC, Lindenberger U, Lohse P, Lubetzki C, Luessi F, Malhotra S, Mescheriakova J, Montalban X, Papeix C, Paredes LF, Rieckmann P, Steinhagen-Thiessen E, Winkelmann A, Zettl UK, Hintzen R, Vandenbroeck K, Stewart G, Fontaine B, Comabella M, Urcelay E, Matesanz F, Sawcer S, Bertram L, Zipp F. International Multiple Sclerosis Genetics Consortium, et al. Among authors: lubetzki c. Brain. 2013 Jun;136(Pt 6):1778-82. doi: 10.1093/brain/awt101. Brain. 2013. PMID: 23739915 Free PMC article.
A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort.
Outteryck O, Ongagna JC, Brochet B, Rumbach L, Lebrun-Frenay C, Debouverie M, Zéphir H, Ouallet JC, Berger E, Cohen M, Pittion S, Laplaud D, Wiertlewski S, Cabre P, Pelletier J, Rico A, Defer G, Derache N, Camu W, Thouvenot E, Moreau T, Fromont A, Tourbah A, Labauge P, Castelnovo G, Clavelou P, Casez O, Hautecoeur P, Papeix C, Lubetzki C, Fontaine B, Couturier N, Bohossian N, Clanet M, Vermersch P, de Sèze J, Brassat D; BIONAT Network,; CFSEP. Outteryck O, et al. Among authors: lubetzki c. Eur J Neurol. 2014;21(1):40-8. doi: 10.1111/ene.12204. Epub 2013 Jun 12. Eur J Neurol. 2014. PMID: 23895407 Clinical Trial.
268 results